Annual Revenue
$12.44 M
-$59.66 M-82.75%
31 December 2022
Summary:
Mirati Therapeutics annual revenue is currently $12.44 million, with the most recent change of -$59.66 million (-82.75%) on 31 December 2022. During the last 3 years, it has fallen by -$59.66 million (-82.75%).MRTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$16.40 M
+$2.71 M+19.80%
30 September 2023
Summary:
Mirati Therapeutics quarterly revenue is currently $16.40 million, with the most recent change of +$2.71 million (+19.80%) on 30 September 2023.MRTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$38.19 M
+$10.97 M+40.29%
30 September 2023
Summary:
Mirati Therapeutics TTM revenue is currently $38.19 million, with the most recent change of +$10.97 million (+40.29%) on 30 September 2023.MRTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -82.8% | +5384.9% | -47.0% |
| 5 y5 years | +272.9% | +3017.9% | +1045.2% |
MRTX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -82.7% | -77.2% | -51.1% |
Mirati Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $16.40 M(+19.8%) | $38.19 M(+40.3%) |
| June 2023 | - | $13.69 M(+91.0%) | $27.22 M(+44.1%) |
| Mar 2023 | - | $7.17 M(+667.3%) | $18.89 M(+51.9%) |
| Dec 2022 | $12.44 M(-82.7%) | $934.00 K(-82.8%) | $12.44 M(+5.4%) |
| Sept 2022 | - | $5.43 M(+1.3%) | $11.80 M(-84.9%) |
| June 2022 | - | $5.36 M(+656.3%) | $78.16 M(+7.4%) |
| Mar 2022 | - | $709.00 K(+137.1%) | $72.80 M(+1.0%) |
| Dec 2021 | $72.09 M(+438.1%) | $299.00 K(-99.6%) | $72.09 M(-1.9%) |
| Sept 2021 | - | $71.79 M(+4103.3%) | $73.50 M(+448.6%) |
| Dec 2020 | $13.40 M(+301.7%) | $1.71 M(-85.0%) | $13.40 M(+9.7%) |
| Sept 2020 | - | $11.42 M(+4178.7%) | $12.22 M(+418.1%) |
| Mar 2020 | - | $267.00 K(-49.2%) | $2.36 M(-29.3%) |
| Dec 2019 | $3.33 M(-74.2%) | $526.00 K(-46.8%) | $3.33 M(-46.8%) |
| Sept 2019 | - | $988.00 K(+71.2%) | $6.27 M(+18.7%) |
| June 2019 | - | $577.00 K(-53.6%) | $5.28 M(+12.3%) |
| Mar 2019 | - | $1.24 M(-64.0%) | $4.70 M(-63.6%) |
| Dec 2018 | $12.93 M(+326.8%) | $3.46 M(-63.5%) | $12.93 M(+36.5%) |
| Mar 2018 | - | $9.47 M(+1794.5%) | $9.47 M(+195.9%) |
| Dec 2011 | $3.03 M(+26.8%) | $499.70 K(+673.5%) | $3.20 M(-10.2%) |
| Sept 2011 | - | $64.60 K(-95.1%) | $3.56 M(-12.4%) |
| June 2011 | - | $1.32 M(-0.4%) | $4.07 M(+25.6%) |
| Mar 2011 | - | $1.32 M(+52.8%) | $3.24 M(+35.9%) |
| Dec 2010 | $2.39 M | $864.10 K(+51.9%) | $2.38 M(+17.5%) |
| Sept 2010 | - | $568.90 K(+17.1%) | $2.03 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $485.70 K(+4.5%) | $1.91 M(+8.6%) |
| Mar 2010 | - | $465.00 K(-8.8%) | $1.76 M(-32.6%) |
| Dec 2009 | $2.88 M(-88.1%) | $509.80 K(+12.4%) | $2.62 M(-79.6%) |
| Sept 2009 | - | $453.70 K(+35.8%) | $12.80 M(-28.3%) |
| June 2009 | - | $334.20 K(-74.7%) | $17.85 M(-17.8%) |
| Mar 2009 | - | $1.32 M(-87.7%) | $21.72 M(-11.4%) |
| Dec 2008 | $24.24 M(+54.8%) | $10.69 M(+94.0%) | $24.51 M(+32.2%) |
| Sept 2008 | - | $5.51 M(+31.0%) | $18.55 M(+10.9%) |
| June 2008 | - | $4.21 M(+2.4%) | $16.72 M(+4.8%) |
| Mar 2008 | - | $4.11 M(-13.0%) | $15.94 M(+7.0%) |
| Dec 2007 | $15.65 M(+13.8%) | $4.72 M(+28.3%) | $14.91 M(+17.5%) |
| Sept 2007 | - | $3.68 M(+7.3%) | $12.69 M(-24.0%) |
| June 2007 | - | $3.43 M(+11.8%) | $16.70 M(+7.2%) |
| Mar 2007 | - | $3.07 M(+22.6%) | $15.57 M(+13.7%) |
| Dec 2006 | $13.75 M(+138.8%) | $2.50 M(-67.4%) | $13.70 M(+13.0%) |
| Sept 2006 | - | $7.69 M(+233.0%) | $12.12 M(+105.9%) |
| June 2006 | - | $2.31 M(+92.7%) | $5.89 M(+12.0%) |
| Mar 2006 | - | $1.20 M(+29.7%) | $5.25 M(-6.3%) |
| Dec 2005 | $5.76 M(-18.3%) | $923.50 K(-36.5%) | $5.61 M(+19.7%) |
| Sept 2005 | - | $1.45 M(-13.3%) | $4.68 M(+45.1%) |
| June 2005 | - | $1.68 M(+8.4%) | $3.23 M(+108.4%) |
| Mar 2005 | - | $1.55 M | $1.55 M |
| Dec 2004 | $7.05 M(-8.6%) | - | - |
| Dec 2003 | $7.71 M | - | - |
FAQ
- What is Mirati Therapeutics annual revenue?
- What is the all time high annual revenue for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Mirati Therapeutics?
- What is Mirati Therapeutics TTM revenue?
- What is the all time high TTM revenue for Mirati Therapeutics?
What is Mirati Therapeutics annual revenue?
The current annual revenue of MRTX is $12.44 M
What is the all time high annual revenue for Mirati Therapeutics?
Mirati Therapeutics all-time high annual revenue is $72.09 M
What is Mirati Therapeutics quarterly revenue?
The current quarterly revenue of MRTX is $16.40 M
What is the all time high quarterly revenue for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly revenue is $71.79 M
What is Mirati Therapeutics TTM revenue?
The current TTM revenue of MRTX is $38.19 M
What is the all time high TTM revenue for Mirati Therapeutics?
Mirati Therapeutics all-time high TTM revenue is $78.16 M